BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25081814)

  • 1. Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.
    Flores-Otero J; Ahn KH; Delgado-Peraza F; Mackie K; Kendall DA; Yudowski GA
    Nat Commun; 2014 Aug; 5():4589. PubMed ID: 25081814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.
    Delgado-Peraza F; Ahn KH; Nogueras-Ortiz C; Mungrue IN; Mackie K; Kendall DA; Yudowski GA
    Mol Pharmacol; 2016 Jun; 89(6):618-29. PubMed ID: 27009233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
    van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.
    Gyombolai P; Boros E; Hunyady L; Turu G
    Mol Cell Endocrinol; 2013 Jun; 372(1-2):116-27. PubMed ID: 23541635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.
    Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
    Pharmacol Res; 2013 Feb; 68(1):46-58. PubMed ID: 23174265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of β-arrestin-2 and clathrin in agonist-mediated internalization of the human cannabinoid CB2 receptor.
    Chen X; Zheng C; Qian J; Sutton SW; Wang Z; Lv J; Liu C; Zhou N
    Curr Mol Pharmacol; 2014; 7(1):67-80. PubMed ID: 25023974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-arrestin-dependent PI(4,5)P
    Jung SR; Jiang Y; Seo JB; Chiu DT; Hille B; Koh DS
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.
    Hamdan FF; Rochdi MD; Breton B; Fessart D; Michaud DE; Charest PG; Laporte SA; Bouvier M
    J Biol Chem; 2007 Oct; 282(40):29089-100. PubMed ID: 17675294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation.
    Eichel K; Jullié D; von Zastrow M
    Nat Cell Biol; 2016 Mar; 18(3):303-10. PubMed ID: 26829388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
    Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB
    Ryalls B; Patel M; Sparkes E; Banister SD; Finlay DB; Glass M
    Biochem Pharmacol; 2024 Apr; 222():116052. PubMed ID: 38354957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
    Goodman OB; Krupnick JG; Santini F; Gurevich VV; Penn RB; Gagnon AW; Keen JH; Benovic JL
    Nature; 1996 Oct; 383(6599):447-50. PubMed ID: 8837779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid 2 receptor- and beta Arrestin 2-dependent upregulation of serotonin 2A receptors.
    Franklin JM; Vasiljevik T; Prisinzano TE; Carrasco GA
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):760-7. PubMed ID: 22841827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of structurally novel G protein biased CB
    Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
    Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).
    Ahn KH; Mahmoud MM; Shim JY; Kendall DA
    J Biol Chem; 2013 Apr; 288(14):9790-9800. PubMed ID: 23449980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors.
    Wu DF; Yang LQ; Goschke A; Stumm R; Brandenburg LO; Liang YJ; Höllt V; Koch T
    J Neurochem; 2008 Feb; 104(4):1132-43. PubMed ID: 17986216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AP-2 adaptor beta2 appendage scaffolds alternate cargo endocytosis.
    Keyel PA; Thieman JR; Roth R; Erkan E; Everett ET; Watkins SC; Heuser JE; Traub LM
    Mol Biol Cell; 2008 Dec; 19(12):5309-26. PubMed ID: 18843039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
    Bajo M; Roberto M; Schweitzer P
    J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.